🔎 Trials Near Me

Akèy › Neuroblastom › Georgia

Etid klinik pou Neuroblastom nan Georgia

9 etid pou Neuroblastom ap chèche patisipan nan sit nan Georgia.

Vil nan Georgia

Tèks ofisyèl etid la (Anglè)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
Ap rekriteFaz 3
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Augusta University Health, Augusta
Ap rekriteFaz 2
Jiska laj 22 · Tout sèks · Mizajou Sep 4, 2026 · NCT02559778

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
Ap rekriteFaz 3
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Augusta University Health, Augusta
Ap rekriteFaz 2
12 Months – 21 Years · Tout sèks · Mizajou Aug 12, 2026 · NCT05489887

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

Neuroblastoma Biology Study

  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
Ap rekriteEtid obsèvasyon
31 Days – 99 Years · Tout sèks · Mizajou Mar 23, 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

  • Children's Healthcare of Atlanta, Atlanta
Ap rekrite
Jiska laj 17 · Tout sèks · Mizajou Feb 10, 2026 · NCT06831552

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

  • Children's Healthcare of Atlanta, Atlanta
Ap rekriteFaz 1
12 Months · Tout sèks · Mizajou Dec 26, 2025 · NCT05400603

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.